-
1.
In circumstances such as those in the main proceedings, where, on the basis of a basic patent and a marketing authorisation for a medicinal product consisting of a combination of several active ingredients, the patent holder has already obtained a supplementary protection certificate for that combination of active ingredients, protected by that patent within the meaning of Article 3(a) of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products, Article 3(c) of that regulation must be interpreted as not precluding the proprietor from also obtaining a supplementary protection certificate for one of those active ingredients which, individually, is also protected as such by that patent.
Article PDF
Avoid common mistakes on your manuscript.
Author information
Consortia
Additional information
Official headnotes.
Available at http://curia.europa.eu.
Rights and permissions
About this article
Cite this article
Decision of the European Court of Justice (Third Chamber) 12 December 2013 – Case No. C-484/12. “Georgetown University”. IIC 45, 589 (2014). https://doi.org/10.1007/s40319-014-0221-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40319-014-0221-z